Beth C. Seidenberg, Director at Vera Therapeutics, Inc. (VERA), sold 29,798 shares at $48.01 ($1.4M) on 2024-10-28, disclosed to the SEC on 2024-10-30.
Scheduled sale ($1.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.01 | 14,798 | $710K | 49.7% |
| 2 | $48.01 | 14,798 | $710K | 49.7% |
| 3 | $49.54 | 202 | $10K | 0.7% |
| Total | $48.02 avg | 29,798 | $1.4M | 100% |
| Filing → |
| SGMT | BUY | 2023-07-20 | $750K | — | Filing → |
| SLRN | BUY | 2023-05-11 | $23.6M | — | Filing → |
| VERA | BUY | 2023-04-03 | $17K | — | Filing → |